[Primary artificial lens implantation in young children with the primary hyperplastic vitreous body]

Insights

Early intraocular lens (IOL) implantation in children with primary persistent hyperplastic vitreous body leads to good visual outcomes. This surgical approach is effective even with severe retinal and optic nerve damage, offering hope for improved vision.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Vitreoretinal Surgery

Background:

  • Primary persistent hyperplastic vitreous body (PHPV) is a congenital condition affecting vision.
  • Surgical intervention for PHPV is often complicated by severe ocular abnormalities.
  • Limited data exists on the long-term functional outcomes of early intraocular lens (IOL) implantation in pediatric PHPV cases.

Purpose of the Study:

  • To evaluate the functional results of early primary intraocular lens (IOL) implantation in children diagnosed with primary persistent hyperplastic vitreous body (PHPV).
  • To compare outcomes between a cohort undergoing IOL implantation and a control group without IOLs.

Main Methods:

  • A comparative study involving 30 children (30 eyes) aged 2 months to 5 years with PHPV.
  • A study group of 12 children received early primary IOL implantation (flexible lenses).
  • A control group of 18 children underwent surgery without IOL implantation.

Main Results:

  • The study group with IOL implantation demonstrated satisfactory functional results.
  • Early IOL implantation yielded positive outcomes despite pre-existing severe retinal and optic nerve changes.
  • Postoperative follow-up ranged from 6 to 40 months, indicating sustained benefits.

Conclusions:

  • Early primary IOL implantation is a viable and effective surgical strategy for managing primary persistent hyperplastic vitreous body in children.
  • This approach can lead to favorable functional outcomes, even in complex cases with significant ocular pathology.
  • The findings support the consideration of early IOL implantation to improve visual prognosis in pediatric PHPV.